公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2014 | Adaptation of international guidelines for metastatic colorectal cancer: An Asian consensus | ANN-LII CHENG ; Li J.; Vaid A.K.; Ma B.B.Y.; Teh C.; Ahn J.B.; Bello M.; Charoentum C.; Chen L.-T.; De Lima Lopes G.; Jr.; Ho G.F.; Kong H.L.; Lam K.O.; Liu T.S.; Park Y.S.; Sriuranpong V.; Sudoyo A.W.; Wang J.-Y.; Zhang J.; Zhang S.Z.; Ciardiello F.; Köhne C.-H.; Shaw M.; Kim T.W. | Clinical Colorectal Cancer | 16 | 15 | |
2004 | Comparison of HPV DNA vaccines employing intracellular targeting strategies | Kim J.W.; Hung C.-F.; Juang J.; He T.; Kim T.W.; Armstrong D.K.; Pai S.I.; PEI-JER CHEN ; Lin C.-T.; Boyd D.A.; Wu T.-C. | Gene Therapy | 106 | 91 | |
2004 | Enhancement of vaccinia vaccine potency by linkage of tumor antigen gene to gene encoding calreticulin | Hsieh C.-J.; Kim T.W.; Hung C.-F.; Juang J.; Moniz M.; Boyd D.A.K.; He L.; PEI-JER CHEN ; CHIEN-HUNG CHEN ; Wu T.-C. | Vaccine | 58 | 56 | |
2004 | Generation and Characterization of DNA Vaccines Targeting the Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus | Kim T.W.; Lee J.H.; Hung C.-F.; Peng S.; Roden R.; Wang M.-C.; Viscidi R.; Tsai Y.-C.; He L.; PEI-JER CHEN ; Boyd D.A.K.; Wu T.-C. | Journal of Virology | 158 | 142 | |
2018 | Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: A JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS | Yoshino T.; Arnold D.; Taniguchi H.; Pentheroudakis G.; Yamazaki K.; Xu R.-H.; Kim T.W.; Ismail F.; Tan I.B.; KUN-HUEI YEH ; Grothey A.; Zhang S.; Ahn J.B.; Mastura M.Y.; Chong D.; Chen L.-T.; Kopetz S.; Eguchi-Nakajima T.; Ebi H.; Ohtsu A.; Cervantes A.; Muro K.; Tabernero J.; Minami H.; Ciardiello F.; Douillard J.-Y. | Annals of Oncology | 431 | 383 | |
2015 | Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): A randomised, double-blind, placebo-controlled, phase 3 trial | Li J.; Qin S.; Xu R.; Yau T.C.C.; Ma B.; Pan H.; Xu J.; Bai Y.; Chi Y.; Wang L.; KUN-HUEI YEH ; Bi F.; Cheng Y.; Le A.T.; Lin J.-K.; Liu T.; Ma D.; Kappeler C.; Kalmus J.; Kim T.W. | The Lancet Oncology | 597 | 536 | |
2004 | Vaccination with a DNA Vaccine Encoding Herpes Simplex Virus Type 1 VP22 Linked to Antigen Generates Long-Term Antigen-Specific CD8-Positive Memory T Cells and Protective Immunity | Kim T.W.; Hung C.-F.; Kim J.W.; Juang J.; PEI-JER CHEN ; He L.; Boyd D.A.K.; Wu T.-C. | Human Gene Therapy | 62 | 51 |